Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Intrathecal Pumps Market, by Application
1.4.2 Europe Intrathecal Pumps Market, by Type
1.4.3 Europe Intrathecal Pumps Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Forces Analysis
Chapter 4. Europe Intrathecal Pumps Market by Application
4.1 Europe Pain Market by Country
4.2 Europe Spasticity Market by Country
Chapter 5. Europe Intrathecal Pumps Market by Type
5.1 Europe Morphine Market by Country
5.2 Europe Ziconotide Market by Country
5.3 Europe Baclofen Market by Country
5.4 Europe Bupivacaine Market by Country
5.5 Europe Clonidine Market by Country
5.6 Europe Others Market by Country
Chapter 6. Europe Intrathecal Pumps Market by Country
6.1 Germany Intrathecal Pumps Market
6.1.1 Germany Intrathecal Pumps Market by Application
6.1.2 Germany Intrathecal Pumps Market by Type
6.2 UK Intrathecal Pumps Market
6.2.1 UK Intrathecal Pumps Market by Application
6.2.2 UK Intrathecal Pumps Market by Type
6.3 France Intrathecal Pumps Market
6.3.1 France Intrathecal Pumps Market by Application
6.3.2 France Intrathecal Pumps Market by Type
6.4 Russia Intrathecal Pumps Market
6.4.1 Russia Intrathecal Pumps Market by Application
6.4.2 Russia Intrathecal Pumps Market by Type
6.5 Spain Intrathecal Pumps Market
6.5.1 Spain Intrathecal Pumps Market by Application
6.5.2 Spain Intrathecal Pumps Market by Type
6.6 Italy Intrathecal Pumps Market
6.6.1 Italy Intrathecal Pumps Market by Application
6.6.2 Italy Intrathecal Pumps Market by Type
6.7 Rest of Europe Intrathecal Pumps Market
6.7.1 Rest of Europe Intrathecal Pumps Market by Application
6.7.2 Rest of Europe Intrathecal Pumps Market by Type
Chapter 7. Company Profiles
7.1 Medtronic PLC
7.1.1 Company overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Product Launches and Product Expansions:
7.1.5.2 Trails and Approvals:
7.1.6 SWOT Analysis
7.2 ICU Medical, Inc. (Smiths Medical)
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expenses
7.3 Teleflex, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental Analysis
7.3.4 Research & Development Expense
7.3.5 SWOT Analysis
7.4 Johnson & Johnson (Johnson & Johnson Services, Inc.)
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental &Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 SWOT Analysis
7.5 Baxter International, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental Analysis
7.5.4 Research & Development Expense
7.5.5 SWOT Analysis
7.6 Abbott Laboratories
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.6.5 SWOT Analysis
7.7 Tricumed Medizintechnik GmbH
7.7.1 Company Overview
7.8 Flowonix Medical, Inc.
7.8.1 Company Overview
7.8.2 Recent strategies and developments:
7.8.2.1 Trails and Approvals:
7.9 DURECT Corporation
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Regional Analysis
7.9.4 Research & Development Expenses
7.10. Novartis AG
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
7.10.5 SWOT Analysis
Unique Offerings 